These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3008524)

  • 41. Interaction of Marek's disease virus with host cell.
    Nazerian K
    Bibl Haematol; 1975 Oct; (43):285-90. PubMed ID: 183685
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on the role of macrophages in Marek's disease of the chicken.
    Powell PC; Hartley KJ; Mustill BM; Rennie M
    J Reticuloendothel Soc; 1983 Oct; 34(4):289-97. PubMed ID: 6312038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latency and tumorigenesis in Marek's disease.
    Nair V
    Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Isolation of the pathogenic virus of Marek's disease from a flock of chickens vaccinated with the turkey herpes vaccine].
    Jurajda V; Halouzka R
    Vet Med (Praha); 1988 Dec; 33(12):741-6. PubMed ID: 2851887
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus.
    Witter RL; Lee LF; Fadly AM
    Avian Dis; 1995; 39(2):269-84. PubMed ID: 7677647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marek's disease and new approaches to its control.
    Zelník V
    Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunoprophylaxis against Marek's disease and its perspectives].
    Schmidt U; Liebermann H; Werner O; Werner P; Prause H
    Arch Exp Veterinarmed; 1980; 34(1):149-54. PubMed ID: 6251769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marek's disease lymphoma of chicken and its causative herpesvirus.
    Nazerian K
    Biochim Biophys Acta; 1979 Nov; 560(3):375-95. PubMed ID: 228727
    [No Abstract]   [Full Text] [Related]  

  • 50. Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus.
    Blaxland JD; Macleod AJ; Hall T
    Vet Rec; 1975 Jul; 97(3):50-2. PubMed ID: 168681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1.
    Katsumata A; Iwata A; Ueda S
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():3015-8. PubMed ID: 9880016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Marek's disease virus BamHI-A-specific cDNA clones obtained from a Marek's disease lymphoblastoid cell line.
    Ohashi K; O'Connell PH; Schat KA
    Virology; 1994 Mar; 199(2):275-83. PubMed ID: 8122361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of Marek's disease using 3 vaccines in chickens belonging to different genetic varieties of meat producers].
    Picault JP; Guittet M; Bennejean G; Goater E
    Dev Biol Stand; 1982; 52():447-53. PubMed ID: 6299854
    [No Abstract]   [Full Text] [Related]  

  • 55. Enhancement of gene expression by Marek's disease virus homologue of the herpes simplex virus-1 ICP4.
    Endoh D
    Jpn J Vet Res; 1996 Aug; 44(2):136-7. PubMed ID: 8870396
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathogenesis of Marek's disease virus infection.
    Calnek BW
    Curr Top Microbiol Immunol; 2001; 255():25-55. PubMed ID: 11217426
    [No Abstract]   [Full Text] [Related]  

  • 57. Sequence analysis of the whole genome of a recombinant Marek's disease virus strain, GX0101, with a reticuloendotheliosis virus LTR insert.
    Su S; Cui N; Sun A; Li Y; Ding J; Chen Z; Zhao P; Cui Z
    Arch Virol; 2013 Sep; 158(9):2007-14. PubMed ID: 23553452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
    Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
    Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vaccinating properties of the Kekava 55 strain of attenuated Marek's disease virus].
    Iakovleva LS; Mazurenko NP
    Vopr Virusol; 1983; 28(6):689-93. PubMed ID: 6322454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.